Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP448253.RAk8vh7b8Hmw-7KfrFbxYWoChWz4MrKTr7bHlll_CY-zI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP448253.RAk8vh7b8Hmw-7KfrFbxYWoChWz4MrKTr7bHlll_CY-zI130_assertion type Assertion NP448253.RAk8vh7b8Hmw-7KfrFbxYWoChWz4MrKTr7bHlll_CY-zI130_head.
- NP448253.RAk8vh7b8Hmw-7KfrFbxYWoChWz4MrKTr7bHlll_CY-zI130_assertion description "[Among those, TLR2 c. -196 to -174 del carriers (ins/del+del/del) showed a significantly decreased risk of GC (adjusted OR, 0.66; 95% CI: 0.48-0.90), whereas TLR5 rs5744174 C carriers (TC+CC) had an increased risk of GC (OR, 1.43; 95% CI: 1.03-1.97).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP448253.RAk8vh7b8Hmw-7KfrFbxYWoChWz4MrKTr7bHlll_CY-zI130_provenance.
- NP448253.RAk8vh7b8Hmw-7KfrFbxYWoChWz4MrKTr7bHlll_CY-zI130_assertion evidence source_evidence_literature NP448253.RAk8vh7b8Hmw-7KfrFbxYWoChWz4MrKTr7bHlll_CY-zI130_provenance.
- NP448253.RAk8vh7b8Hmw-7KfrFbxYWoChWz4MrKTr7bHlll_CY-zI130_assertion SIO_000772 21994405 NP448253.RAk8vh7b8Hmw-7KfrFbxYWoChWz4MrKTr7bHlll_CY-zI130_provenance.
- NP448253.RAk8vh7b8Hmw-7KfrFbxYWoChWz4MrKTr7bHlll_CY-zI130_assertion wasDerivedFrom befree-20140225 NP448253.RAk8vh7b8Hmw-7KfrFbxYWoChWz4MrKTr7bHlll_CY-zI130_provenance.
- NP448253.RAk8vh7b8Hmw-7KfrFbxYWoChWz4MrKTr7bHlll_CY-zI130_assertion wasGeneratedBy ECO_0000203 NP448253.RAk8vh7b8Hmw-7KfrFbxYWoChWz4MrKTr7bHlll_CY-zI130_provenance.